Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 17 most recent Form 4 transactions.
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 9,398 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 1.2M | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 93,000 | — | — | -100.0% | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 23,832 | — | — | — | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 26,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 23,832 | $19.97 | $475.9K | +34.5% | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 13,000 | $25.20 | $327.6K | +23.1% | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 13,000 | $26.32 | $342.2K | +30.1% | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 15,000 | $8.13 | $122K | +53.3% | Open the original filing on SEC.gov |
| Oct 8, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 26,000 | $23.02 | $598.5K | +1,199% | Open the original filing on SEC.gov |
| Jun 11, 2025 | OLMA | Olema Pharmaceuticals,… | AGRANT◆ | 24,150 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | AKRO | Akero Therapeutics, Inc. | AGRANT | 9,398 | — | — | +433.5% | Open the original filing on SEC.gov |